AGM/EGMApr 29, 2026, 04:53 PM
CLDI to Vote on 1:2-1:16 Reverse Stock Split, Equity Plan Increase
AI Summary
Calidi Biotherapeutics, Inc. will hold its virtual Annual Meeting of Stockholders on June 12, 2026. Stockholders will vote on several key proposals, including the election of Class III directors, the ratification of CBIZ CPAs P.C. as the independent auditor, and a proposal to effect a reverse stock split at a ratio between 1-for-2 and 1-for-16 at the Board's discretion. Additionally, stockholders will consider an amendment to increase the shares authorized under the 2023 Equity Incentive Plan from 282,815 to 1,950,000.
Key Highlights
- Annual Meeting scheduled for June 12, 2026, at 10:00 a.m. Pacific Time, virtually.
- Record date for voting is April 17, 2026.
- Proposing a reverse stock split with a ratio between 1-for-2 and 1-for-16.
- Seeking to increase 2023 Equity Incentive Plan shares from 282,815 to 1,950,000.
- Stockholders to vote on election of Class III directors.
- Ratification of CBIZ CPAs P.C. as independent auditor.
- 15,228,625 shares of Common Stock outstanding and entitled to vote.